Investigating feasibility of 2021 WHO protocol for cervical cancer screening in underscreened populations: PREvention and SCReening Innovation Project Toward Elimination of Cervical Cancer (PRESCRIP-TEC)

doi:10.1186/s12889-022-13488-z

Clinical Trial

. 2022 Jul 15;22(1):1356.

doi: 10.1186/s12889-022-13488-z.

Investigating feasibility of 2021 WHO protocol for cervical cancer screening in underscreened populations: PREvention and SCReening Innovation Project Toward Elimination of Cervical Cancer (PRESCRIP-TEC)

Marat Sultanov¹, Janine de Zeeuw², Jaap Koot², Jurjen van der Schans^{2

3}, Jogchum J Beltman⁴, Marlieke de Fouw⁴, Marek Majdan⁵, Martin Rusnak⁵, Naheed Nazrul⁶, Aminur Rahman⁷, Carolyn Nakisige⁸, Arathi P Rao⁹, Keerthana Prasad¹⁰, Shyamala Guruvare¹¹, Regien Biesma², Marco Versluis¹², Geertruida H de Bock^#¹³, Jelle Stekelenburg^#^{2

14}

Affiliations

¹ Department of Health Sciences, Global Health Unit, University Medical Center Groningen, University of Groningen, Groningen, Netherlands. m.sultanov@umcg.nl.
² Department of Health Sciences, Global Health Unit, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
³ Department of Economics, Econometrics and Finance, Faculty of Economics and Business, University of Groningen, Groningen, Netherlands.
⁴ Department of Gynecology, Leiden University Medical Centre, Leiden University, Leiden, Netherlands.
⁵ Institute for Global Health and Epidemiology, Department of Public Health, Faculty of Health Sciences and Social Work, Trnava University, Trnava, Slovak Republic.
⁶ Friendship Foundation, Dhaka, Bangladesh.
⁷ Health System and Population Studies Division, icddr,b, Dhaka, Bangladesh.
⁸ Uganda Cancer Institute, Kampala, Uganda.
⁹ Prasanna School of Public Health, Manipal Academy of Higher Education, Manipal, India.
¹⁰ Manipal School of Information Sciences, Manipal Academy of Higher Education, Manipal, India.
¹¹ Kasturba Medical College, Manipal Academy of Higher Education, Manipal, India.
¹² Department of Obstetrics and Gynecology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
¹³ Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
¹⁴ Department of Obstetrics and Gynecology, Medical Center Leeuwarden, Leeuwarden, Netherlands.

^# Contributed equally.

PMID: 35840949
PMCID: PMC9284962
DOI: 10.1186/s12889-022-13488-z

Free PMC article

Clinical Trial

Investigating feasibility of 2021 WHO protocol for cervical cancer screening in underscreened populations: PREvention and SCReening Innovation Project Toward Elimination of Cervical Cancer (PRESCRIP-TEC)

Marat Sultanov et al. BMC Public Health. 2022.

Free PMC article

. 2022 Jul 15;22(1):1356.

doi: 10.1186/s12889-022-13488-z.

Authors

Affiliations

¹ Department of Health Sciences, Global Health Unit, University Medical Center Groningen, University of Groningen, Groningen, Netherlands. m.sultanov@umcg.nl.
² Department of Health Sciences, Global Health Unit, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
³ Department of Economics, Econometrics and Finance, Faculty of Economics and Business, University of Groningen, Groningen, Netherlands.
⁴ Department of Gynecology, Leiden University Medical Centre, Leiden University, Leiden, Netherlands.
⁵ Institute for Global Health and Epidemiology, Department of Public Health, Faculty of Health Sciences and Social Work, Trnava University, Trnava, Slovak Republic.
⁶ Friendship Foundation, Dhaka, Bangladesh.
⁷ Health System and Population Studies Division, icddr,b, Dhaka, Bangladesh.
⁸ Uganda Cancer Institute, Kampala, Uganda.
⁹ Prasanna School of Public Health, Manipal Academy of Higher Education, Manipal, India.
¹⁰ Manipal School of Information Sciences, Manipal Academy of Higher Education, Manipal, India.
¹¹ Kasturba Medical College, Manipal Academy of Higher Education, Manipal, India.
¹² Department of Obstetrics and Gynecology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
¹³ Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
¹⁴ Department of Obstetrics and Gynecology, Medical Center Leeuwarden, Leeuwarden, Netherlands.

^# Contributed equally.

PMID: 35840949
PMCID: PMC9284962
DOI: 10.1186/s12889-022-13488-z

Abstract

Background: High-risk human papillomavirus (hrHPV) testing has been recommended by the World Health Organization as the primary screening test in cervical screening programs. The option of self-sampling for this screening method can potentially increase women's participation. Designing screening programs to implement this method among underscreened populations will require contextualized evidence.

Methods: PREvention and SCReening Innovation Project Toward Elimination of Cervical Cancer (PRESCRIP-TEC) will use a multi-method approach to investigate the feasibility of implementing a cervical cancer screening strategy with hrHPV self-testing as the primary screening test in Bangladesh, India, Slovak Republic and Uganda. The primary outcomes of study include uptake and coverage of the screening program and adherence to follow-up. These outcomes will be evaluated through a pre-post quasi-experimental study design. Secondary objectives of the study include the analysis of client-related factors and health system factors related to cervical cancer screening, a validation study of an artificial intelligence decision support system and an economic evaluation of the screening strategy.

Discussion: PRESCRIP-TEC aims to provide evidence regarding hrHPV self-testing and the World Health Organization's recommendations for cervical cancer screening in a variety of settings, targeting vulnerable groups. The main quantitative findings of the project related to the impact on uptake and coverage of screening will be complemented by qualitative analyses of various determinants of successful implementation of screening. The study will also provide decision-makers with insights into economic aspects of implementing hrHPV self-testing, as well as evaluate the feasibility of using artificial intelligence for task-shifting in visual inspection with acetic acid.

Trial registration: ClinicalTrials.gov, NCT05234112 . Registered 10 February 2022.

Keywords: Bangladesh; Cervical cancer; Cervical cancer screening; Human papillomavirus testing; Implementation; India; Slovakia; Uganda.

PubMed Disclaimer

Cited by

The effect of hrHPV prevalence on cervical cancer screening strategies: a cost-effectiveness study of Bangladesh.
Pan F, van der Schans J, Nazrul N, Koot JAR, Beltman J, Greuter MJW, de Bock GH. Pan F, et al. BMC Public Health. 2025 Feb 11;25(1):561. doi: 10.1186/s12889-025-21756-x. BMC Public Health. 2025. PMID: 39934769 Free PMC article.
Exploring the possibilities and limitations of customized large language model to support and improve cervical cancer screening.
Angyal V, Bertalan Á, Domján P, Dinya E. Angyal V, et al. BMC Med Inform Decis Mak. 2025 Jul 1;25(1):242. doi: 10.1186/s12911-025-03088-3. BMC Med Inform Decis Mak. 2025. PMID: 40597085 Free PMC article.
Cervical cancer screening programs for female sex workers: a scoping review.
Vimpere L, Sami J, Jeannot E. Vimpere L, et al. Front Public Health. 2023 Sep 29;11:1226779. doi: 10.3389/fpubh.2023.1226779. eCollection 2023. Front Public Health. 2023. PMID: 37841741 Free PMC article.
Factors influencing implementation of a care coordination intervention for cancer survivors with multiple comorbidities in a safety-net system: an application of the Implementation Research Logic Model.
Rodriguez SA, Lee SC, Higashi RT, Chen PM, Eary RL, Sadeghi N, Santini N, Balasubramanian BA. Rodriguez SA, et al. Implement Sci. 2023 Dec 4;18(1):68. doi: 10.1186/s13012-023-01326-8. Implement Sci. 2023. PMID: 38049844 Free PMC article.
High-risk human papillomavirus testing for underscreened populations: cost-effectiveness and affordability in three country settings.
Sultanov M, de Bock GH, Koot JAR, de Zeeuw J, Greuter MJW, Pan F, Stekelenburg J, Beltman JJ, de Fouw M, Nakisige C, Kabukye JK, Anecho E, Nazrul N, Kulsum MU, Rahman A, Majdan M, Melichová J, Sokolová J, van der Schans J. Sultanov M, et al. BMC Public Health. 2025 Jul 29;25(1):2570. doi: 10.1186/s12889-025-23791-0. BMC Public Health. 2025. PMID: 40731006 Free PMC article.

See all "Cited by" articles

References

1. Asian Pac J Cancer Prev. 2013;14(12):7761-2 - PubMed
1. Lancet. 2020 Feb 22;395(10224):575-590 - PubMed
1. Sex Med Rev. 2020 Jan;8(1):28-37 - PubMed
1. CA Cancer J Clin. 2021 May;71(3):209-249 - PubMed
1. Implement Sci. 2007 Nov 30;2:40 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Associated data

Actions
- Search in PubMed
- Search in ClinicalTrials.gov

LinkOut - more resources

[1] Asian Pac J Cancer Prev. 2013;14(12):7761-2 - PubMed

[2] Asian Pac J Cancer Prev. 2013;14(12):7761-2 - PubMed

[3] Lancet. 2020 Feb 22;395(10224):575-590 - PubMed

[4] Lancet. 2020 Feb 22;395(10224):575-590 - PubMed

[5] Sex Med Rev. 2020 Jan;8(1):28-37 - PubMed

[6] Sex Med Rev. 2020 Jan;8(1):28-37 - PubMed

[7] CA Cancer J Clin. 2021 May;71(3):209-249 - PubMed

[8] CA Cancer J Clin. 2021 May;71(3):209-249 - PubMed

[9] Implement Sci. 2007 Nov 30;2:40 - PubMed

[10] Implement Sci. 2007 Nov 30;2:40 - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Investigating feasibility of 2021 WHO protocol for cervical cancer screening in underscreened populations: PREvention and SCReening Innovation Project Toward Elimination of Cervical Cancer (PRESCRIP-TEC)

Affiliations

Investigating feasibility of 2021 WHO protocol for cervical cancer screening in underscreened populations: PREvention and SCReening Innovation Project Toward Elimination of Cervical Cancer (PRESCRIP-TEC)

Authors

Affiliations

Abstract

Similar articles

Cited by

References

Publication types

MeSH terms

Associated data

LinkOut - more resources

Full Text Sources

Medical